Shield Therapeutics

VC hits a high for U.K. biotech, but 'dark spots' remain

Although not as traditionally as strong as the U.S. market, the U.K. venture capital funding rounds for biotechs hit record levels last year as $489 million ($692million) was raised.

Ben Adams Jun 16, 2016 5:36am